Zealand Pharma A/S (Nasdaq: ZEAL) today announced that Boehringer Ingelheim has reported that up to …
Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study
Boehringer Ingelheim and Carelon Research have conducted a validation study of the Klinrisk model, a …
